Servier Symphogen A/S
CVR: 10013267
Secondary names: Symphogen A/S
Servier Symphogen A/S demonstrates a strong recovery in financial health, with significant growth in revenue and profit over the past few years. Revenue surged from 70 million DKK in 2022 to nearly 594 million DKK in 2025, while profit has remained relatively stable, increasing from 37 million DKK in 2024 to 39 million DKK in 2025. However, the equity position has seen fluctuations, dropping to 162 million DKK in 2025 from 223 million DKK in 2024, indicating potential concerns regarding long-term sustainability. The company is positioned well within the research and experimental development sector, showcasing resilience and growth potential despite past equity challenges.
AI-generated summary
Overview
Details
Contact
Purpose
Selskabets formål er at forske, udvikle, producere og sælge, herunder gennem ind- og udlicensering, produkter, processer, teknologier, service og andre beslægtede forretningsområder efter bestyrelsens skøn.
Location
Financials
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | 593.8 mio. | 39.1 mio. | 390.9 mio. | 162.9 mio. | 159 | |
History
Ownership
Management
Directors
Board
Founders
Production units (2)
Similar companies
Companies in the same industry and area